Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 5Thoracic 4Other solid neoplasm 3Gastrointestinal 2

Conditions

Stomach Neoplasms 1Carcinoma, Hepatocellular 1Advanced Gastric Cancer 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
vorolanib × Gastrointestinal × Clear all
NCT03511222 2020-07-29

Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors

Washington University School of Medicine

Phase 1 Terminated
16 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Stomach Neoplasms

NCT03286244 2019-02-21

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

AnewPharma

Phase 1 Unknown
21 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡